InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,584.54
(
-0.88%
)
US TECH 100
19,681.20
(
-2.17%
)
Dow Jones
39,753.75
(
0.08%
)
Brent Oil
85.31
(
0.23%
)
Bitcoin
57,554.90
(
0.36%
)
Post# of 252581
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 89
Posts 17484
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: DewDiligence post# 65955

Monday, 09/08/2008 10:12:18 PM

Monday, September 08, 2008 10:12:18 PM

Post# of 252581
Re: BIOD's insulin variant

It's not quite fair to say that it was only stat sig by excluding India, as that was the Type I trial only (and type II is obviously the "market").

OTOH, I suspect the real issue is that it was stat sig inferior to Humulin, despite being stat sig non-inferior (yes, I think I said that right). How common is that?

It's probably not a good idea to have an also ran in this market.


Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up